title: [Mandibular advancement devices in the treatment of obstructive sleep apnea].
abstract: Obstructive sleep apnea (OSA) affects approximately 450,000 people in Poland. Use of nasal continuous positive airway pressure (nCPAP) devices and laryngeal surgery are widely accepted OSA treatment methods. In 1995 ASDA approved oral devices for treatment of OSA patients. The aim of the study was to determine efficiency of mandibular advancement devices (MAD) in OSA therapy.
  
  
  METHODS
  The study group included 20 patients with OSA, all of whom did not tolerate nCPAP and did not have indications or did not agree for surgical treatment.
  
  
  RESULTS
  Control polysomnography was carried out in 11 patients using MAD. In 64% of patients AHI was lower then 10. No correlation between MAD use and AHI values was found. 45% of patients declared improvement of sleep quality and life comfort.
  
  
  CONCLUSIONS
  Use of mandibular advancement devices is an important alternative therapy of OSA.
authors.affiliation: Klinika Chorób Wewnetrznych Pneumonologii i Alergologii Akademii Medycznej w Warszawie. pkorczyn@amwaw.edu.pl
authors.forename: Piotr
authors.initials: P
authors.lastname: Korczyński
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Górska
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Wilk
authors.forename: Piotr
authors.initials: P
authors.lastname: Bielicki
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Byśkiniewicz
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Baczkowski
mesh_terms: D000328:Adult; D000368:Aged; D015992:Body Mass Index; D045422:Continuous Positive Airway Pressure / Q000295:instrumentation; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D019186:Mandibular Advancement / Q000295:instrumentation*; D008875:Middle Aged; D020181:Sleep Apnea, Obstructive / Q000628:therapy*